Prostate Specific Antigen News and Research

RSS
AUA clarifes recommendations on prostate cancer testing with PSA test and DRE

AUA clarifes recommendations on prostate cancer testing with PSA test and DRE

Blood vessels good indicators of prostate cancer behavior

Blood vessels good indicators of prostate cancer behavior

Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia

Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia

Astellas enters into agreement with Medivation to develop MDV3100

Astellas enters into agreement with Medivation to develop MDV3100

New tools needed to identify men and women at risk for the most aggressive cancers

New tools needed to identify men and women at risk for the most aggressive cancers

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Magnetic resonance imaging to help diagnose hidden prostate cancer

Magnetic resonance imaging to help diagnose hidden prostate cancer

PSA test vital for assessing prostate cancer

PSA test vital for assessing prostate cancer

Effective decision support tools may help decide whether or not to undertake PSA screening

Effective decision support tools may help decide whether or not to undertake PSA screening

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Statistical modeling used to estimate benefits and risks of PSA screening

Statistical modeling used to estimate benefits and risks of PSA screening

Radiation treatment after prostate cancer surgery eradicates recurrent cancer

Radiation treatment after prostate cancer surgery eradicates recurrent cancer

Medivation commences patient treatment in clinical trial of MDV3100 in advanced prostate cancer

Medivation commences patient treatment in clinical trial of MDV3100 in advanced prostate cancer

ColoMarker assay achieves 100 percent detection rate for colon cancers

ColoMarker assay achieves 100 percent detection rate for colon cancers

PCEC to provide free prostate cancer screenings

PCEC to provide free prostate cancer screenings

Research study investigates survival rates of prostate cancer patients across time periods

Research study investigates survival rates of prostate cancer patients across time periods

GENova to file for Prostaganin patents in the US and in Europe

GENova to file for Prostaganin patents in the US and in Europe

GENova Biotherapeutics to obtain three new drug target patents

GENova Biotherapeutics to obtain three new drug target patents

Protox' Phase 2 study of PRX302 for treating BPH provides positive results

Protox' Phase 2 study of PRX302 for treating BPH provides positive results

Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics

Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.